- Home
- FSUN vs MNKD Comparison
FSUN vs MNKD Comparison
Compare FSUN & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSUN
- MNKD
- Stock Information
- Founded
- FSUN 1892
- MNKD 1991
- Country
- FSUN United States
- MNKD United States
- Employees
- FSUN N/A
- MNKD N/A
- Industry
- FSUN Major Banks
- MNKD Biotechnology: Pharmaceutical Preparations
- Sector
- FSUN Finance
- MNKD Health Care
- Exchange
- FSUN Nasdaq
- MNKD Nasdaq
- Market Cap
- FSUN 1.1B
- MNKD 1.2B
- IPO Year
- FSUN N/A
- MNKD 2004
- Fundamental
- Price
- FSUN $35.93
- MNKD $3.87
- Analyst Decision
- FSUN Buy
- MNKD Buy
- Analyst Count
- FSUN 4
- MNKD 6
- Target Price
- FSUN $47.33
- MNKD $9.33
- AVG Volume (30 Days)
- FSUN 126.2K
- MNKD 2.5M
- Earning Date
- FSUN 07-28-2025
- MNKD 08-11-2025
- Dividend Yield
- FSUN N/A
- MNKD N/A
- EPS Growth
- FSUN N/A
- MNKD 228.27
- EPS
- FSUN 3.14
- MNKD 0.10
- Revenue
- FSUN $380,544,000.00
- MNKD $297,595,000.00
- Revenue This Year
- FSUN $18.21
- MNKD $13.62
- Revenue Next Year
- FSUN $6.77
- MNKD $15.18
- P/E Ratio
- FSUN $11.61
- MNKD $37.26
- Revenue Growth
- FSUN 10.96
- MNKD 32.50
- 52 Week Low
- FSUN $31.70
- MNKD $3.51
- 52 Week High
- FSUN $45.32
- MNKD $7.63
- Technical
- Relative Strength Index (RSI)
- FSUN 40.54
- MNKD 48.28
- Support Level
- FSUN $38.06
- MNKD $3.81
- Resistance Level
- FSUN $39.36
- MNKD $4.13
- Average True Range (ATR)
- FSUN 1.43
- MNKD 0.16
- MACD
- FSUN -0.34
- MNKD 0.02
- Stochastic Oscillator
- FSUN 8.53
- MNKD 35.00
About FSUN FirstSun Capital Bancorp
Firstsun Capital Bancorp is the financial holding company. It provides a full range of deposit, lending, treasury management, wealth management, and online banking products and services. The company operates in two segments - Banking operations and mortgage operations, the majority of which are generated by the banking operations segment. The Banking segment originates loans and provides deposits and fee based services to consumer, business, and mortgage lending customers. Products offered include a full range of commercial and consumer banking and financial services. The Mortgage Operations segment originates, sells, services, and manages market risk from changes in interest rates on one-to-four family residential mortgage loans.
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.